project id: TCGA-MESO; case submitter id: TCGA-3H-AB3K; concentration: 0.16; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 8.0; age at index: 64; days to birth: -23591; days to death: 1715; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1944; year of death: 2012; age at diagnosis: 23591; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C45.0; last known disease status: not reported; morphology: 9050/3; primary diagnosis: Mesothelioma, malignant; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pleura, NOS; synchronous malignancy: No; tissue or organ of origin: Pleura, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1935; initial weight: 90.0; oct embedded: false; preservation method: Unknown; sample id: d101d5b2-4130-42cf-bbe8-ab817cc0d5cb; sample submitter id: TCGA-3H-AB3K-01A; portion id: 3c50eee6-63b2-43a4-804b-4c5b53919f6e; portion submitter id: TCGA-3H-AB3K-01A-11; slide id: 2c209185-171f-4bbe-b035-3f4483d58d90; slide submitter id: TCGA-3H-AB3K-01A-01-TS1; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; section location: TOP;